Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04JIM
|
|||
| Former ID |
DIB000176
|
|||
| Drug Name |
UCB-35440
|
|||
| Synonyms |
5-[4-(N-Carbamoyl-N-hydroxyamino)-1-butynyl]-2-[2-[4-[1(R)-(4-chlorophenyl)-1-phenylmethyl]piperazin-1-yl]ethoxy]benzamide
Click to Show/Hide
|
|||
| Indication | Rhinitis [ICD-11: FA20; ICD-10: J31.0] | Phase 2 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C31H34ClN5O4
|
|||
| Canonical SMILES |
C1CN(CCN1CCOC2=C(C=C(C=C2)C#CCCN(C(=O)N)O)C(=O)N)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl
|
|||
| InChI |
1S/C31H34ClN5O4/c32-26-12-10-25(11-13-26)29(24-7-2-1-3-8-24)36-18-16-35(17-19-36)20-21-41-28-14-9-23(22-27(28)30(33)38)6-4-5-15-37(40)31(34)39/h1-3,7-14,22,29,40H,5,15-21H2,(H2,33,38)(H2,34,39)/t29-/m1/s1
|
|||
| InChIKey |
KHVLZYHEWIBDOU-GDLZYMKVSA-N
|
|||
| CAS Number |
CAS 299460-62-1
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of UCB. | |||
| REF 2 | The effect of a novel, dual function histamine H1 receptor antagonist/5-lipoxygenase enzyme inhibitor on in vivo dermal inflammation and extravasat... Eur J Pharmacol. 2005 Jan 4;506(3):265-71. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.